A previous study showed that tangeretin inhibits COX-2 expression induced by IL-1beta in A549 lung cancer cells by inhibiting NF-kB, p38 MAPK, JNK, and PI3K signaling [42]. This evidence concerns the gene NFKB1 and lung cancer.